Alzamend Neuro Inc

ALZN | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.94

+$0.05 (+2.65%)

At close: Sep 21, 2026, 4:00 PM ET

$1.93

-$0.01 (-0.52%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $7.19M

Enterprise Value $-210.25K

Beta 0.19

Average Volume 129.53K

Shares Outstanding (Diluted) 4.48M

Shares Change YoY 112.66%

Institutional Ownership 17.93%

Exchange NASDAQ

ISIN US02262M6057

Price Performance

Price Change 1M 30.2%

Price Change 3M 41.6%

Price Change 6M 0.5%

Price Change YTD 2.1%

Price Change 1Y -18.1%

Price Change 3Y -99.3%

Price Change 5Y -99.9%

1M CAGR (ann.) 37.0%

1Y CAGR (ann.) -24.4%

5Y CAGR (ann.) -78.4%

All-Time CAGR -82.5%

Valuation

PE Ratio -0.84

Forward PE N/A

PEG Ratio -0.00

Forward PEG 0.05

PS Ratio N/A

Forward PS 0.20

PB Ratio 1.27

P/FCF Ratio -1.08

P/Adj. FCF Ratio -1.06

P/OCF Ratio -1.27

EV/Sales N/A

EV/EBIT 0.02

EV/EBITDA 0.02

EV/FCF 0.03

Earnings Yield -118.6%

FCF Yield -92.7%

Adj. FCF Yield -94.3%

Financial Health

Net Cash $7.59M

Total Debt $0

Cash & Short-Term Investments $7.59M

Total Assets $8.54M

Current Ratio 3.01

Quick Ratio 3.01

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 818.59

Altman Z-Score -12.69

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -1.7%

Returns

Return on Assets -106.5%

Return on Equity -277.9%

Return on Invested Capital -156.7%

Return on Capital Employed -156.7%

Return on Tangible Assets -106.5%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y -54.5%

EPS CAGR 3Y 131.0%

EPS CAGR 5Y 56.8%

EPS CAGR 10Y 2.8%

FCF CAGR 3Y -5.2%

FCF CAGR 5Y 5.3%

FCF CAGR 10Y -17.7%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 1

EPS Growth Next 3Y 20.9%

Revenue Growth Next 3Y N/A

Earnings Date Dec 7, 2026

EPS Estimate (next Q) -$0.23

EPS Growth Est (next Q) -23.3%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $26

Price Target Upside 1240.2%

Cash Flow

Operating Cash Flow $-6.84M

Free Cash Flow $-6.84M

Adj. Free Cash Flow $-6.96M

FCF Per Share -$1.53

OCF Per Share -$1.53

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-55.37K

Operating Income $-9.09M

EBITDA $-9.12M

Net Income $-9.1M

EPS (Diluted) -$2.30

Revenue / Employee N/A

Profit / Employee $-1.52M

Employees 6